Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition

Författare

  • Anna Luczynska
  • Rudolf Kaaks
  • Sabine Rohrmann
  • Susen Becker
  • Jakob Linseisen
  • Brian Buijsse
  • Kim Overvad
  • Antonia Trichopoulou
  • Elisavet Valanou
  • Antonia Barmpitsioti
  • Giovanna Masala
  • Claudia Agnoli
  • Rosario Tumino
  • Salvatore Panico
  • H. Bas Bueno-de-Mesquita
  • Franzel J. B. van Duijnhoven
  • Petra H. M. Peeters
  • Roel Vernieulen
  • Elisabete Weiderpass
  • Magritt Brustad
  • Guri Skeie
  • Carlos A. Gonzalez
  • Paula Jakszyn
  • J. Ramon Quiros
  • Maria-Jose Sanchez
  • Jose-Maria Huerta
  • Eva Ardanaz
  • Beatrice Melin
  • Ann Sofie Johansson
  • Martin Almquist
  • Johan Malm
  • Kay-Tee Khaw
  • Nick Wareham
  • Ruth C. Travis
  • Veronika Fedirko
  • Isabelle Romieu
  • Mazda Jenab
  • Valentina Gallo
  • Elio Riboli
  • Paolo Vineis
  • Alexandra Nieters

Summary, in English

Background: The relation between vitamin D status and lymphoma risk is inconclusive. Objective: We examined the association between prediagnostic plasma 25-hydroxyvitamin D [25(OH)D] and lymphoid cancer risk. Design: We conducted a study nested within the European Prospective Investigation into Cancer and Nutrition cohort of 1127 lymphoma cases and 1127 matched controls with a mean follow-up time of 7.1 y. Conditional logistic regression was used to estimate multivariable-adjusted incidence rate ratios of lymphoma risk in relation to plasma 25(OH)D. Season-standardized and season-specific 25(OH)D quartiles were used. We also analyzed 25(OH)D as a continuous variable and used predefined cutoffs. Results: No statistically significant association between plasma 25(OH)D and overall lymphoid cancer risk was observed. A positive association for B-cell non-Hodgkin lymphoma was noted only in those with a diagnosis made during the first 2 y of follow-up (P-heterogeneity = 0.03), which suggests the possibility of reverse causality. Further analysis restricted to participants with >= 2y of follow-up time showed a significant association between 25(OH)D and chronic lymphocytic leukemia (CLL) (n = 161): adjusted incidence rate ratios were 0.40 (95% CI: 0.18, 0.90; P-trend = 0.05) and 0.31 (95% CI: 0.13, 0.76; P-trend = 0.03) for the top compared with the bottom season-standardized and season-specific quartiles, respectively. Data on dietary vitamin D intake provided further support for the observed association (incidence rate ratio: 0.33; 95% CI = 0.12, 0.89; P-trend = 0.006). Conclusions: Our findings do not support a protective role of high 25(OH)D concentration in lymphoid cancers overall. However, they suggest that higher concentrations of 25(OH)D are associated with a reduced risk of CLL.

Publiceringsår

2013

Språk

Engelska

Sidor

827-838

Publikation/Tidskrift/Serie

American Journal of Clinical Nutrition

Volym

98

Issue

3

Dokumenttyp

Artikel i tidskrift

Förlag

Oxford University Press

Ämne

  • Nutrition and Dietetics

Status

Published

Forskningsgrupp

  • Clinical Chemistry, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1938-3207